126 related articles for article (PubMed ID: 9692812)
1. Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplot.
Van den Hove LE; Meeus P; Derom A; Demuynck H; Verhoef GE; Vandenberghe P; Boogaerts MA
Ann Hematol; 1998 Jun; 76(6):249-56. PubMed ID: 9692812
[TBL] [Abstract][Full Text] [Related]
2. Multivariate reconstruction of lymphocyte profiles in a two-dimensional graphical model as a tool for the investigation of lymphocyte subset distribution in health and disease.
Van den Hove LE; Symons F; Vandenberghe P; Verhoef GE; Demuynck H; Van Gool SW; Ceuppens JL; Boogaerts MA
Cytometry; 1997 Jul; 28(3):220-7. PubMed ID: 9222107
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment.
Van den Hove LE; Vandenberghe P; Van Gool SW; Ceuppens JL; Demuynck H; Verhoef GE; Boogaerts MA
Leuk Res; 1998 Feb; 22(2):175-84. PubMed ID: 9593474
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
Tienhaara A; Pelliniemi TT
Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
6. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
[TBL] [Abstract][Full Text] [Related]
7. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
[TBL] [Abstract][Full Text] [Related]
9. CD57+/CD28- T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis.
Van den Hove LE; Van Gool SW; Vandenberghe P; Boogaerts MA; Ceuppens JL
Leukemia; 1998 Oct; 12(10):1573-82. PubMed ID: 9766502
[TBL] [Abstract][Full Text] [Related]
10. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
Allegra A; Innao V; Allegra AG; Pugliese M; Di Salvo E; Ventura-Spagnolo E; Musolino C; Gangemi S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185596
[TBL] [Abstract][Full Text] [Related]
14. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
[TBL] [Abstract][Full Text] [Related]
15. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
[TBL] [Abstract][Full Text] [Related]
17. CD5 B lymphocyte antigen in monoclonal gammopathy.
Bataille R; Duperray C; Zhang XG; Brochier J; Klein B
Am J Hematol; 1992 Oct; 41(2):102-6. PubMed ID: 1384312
[TBL] [Abstract][Full Text] [Related]
18. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
19. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.
Serra HM; Mant MJ; Ruether BA; Ledbetter JA; Pilarski LM
J Clin Immunol; 1988 Jul; 8(4):259-65. PubMed ID: 2970472
[TBL] [Abstract][Full Text] [Related]
20. Mass Cytometry Discovers Two Discrete Subsets of CD39
Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S
Front Immunol; 2019; 10():1596. PubMed ID: 31428081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
